# Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

> **NCT04535427** · PHASE2 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 144 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** L-arginine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04535427
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2020-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04535427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04535427, "Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04535427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*